Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Free Cash Flow: 2018-2024

Historic Free Cash Flow for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to -$192.2 million.

  • Legend Biotech's Free Cash Flow rose 186.09% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$171.0 million, marking a year-over-year decrease of 7.35%. This contributed to the annual value of -$192.2 million for FY2024, which is 58.19% up from last year.
  • As of FY2024, Legend Biotech's Free Cash Flow stood at -$192.2 million, which was up 58.19% from -$459.5 million recorded in FY2023.
  • Legend Biotech's 5-year Free Cash Flow high stood at -$192.2 million for FY2024, and its period low was -$459.5 million during FY2023.
  • Its 3-year average for Free Cash Flow is -$294.2 million, with a median of -$231.0 million in 2022.
  • As far as peak fluctuations go, Legend Biotech's Free Cash Flow slumped by 136.30% in 2020, and later spiked by 58.19% in 2024.
  • Legend Biotech's Free Cash Flow (Yearly) stood at -$259.5 million in 2020, then grew by 6.86% to -$241.7 million in 2021, then rose by 4.45% to -$231.0 million in 2022, then slumped by 98.96% to -$459.5 million in 2023, then skyrocketed by 58.19% to -$192.2 million in 2024.